Unformatted text preview: has every right to these patents in question. But seeing as how Supreme Court cases can overturn and adjust laws, it probably is important to consider ethics. Ethically it comes down to whether more good is generated from freedom of this particular application or from the monetary backing of Pharmaceutical companies. I think now I’m more convinced that upholding this patent helps research and identification more than it hurts. All I know is I do not envy the work Myriad’s lawyers have before them if the Supreme Court takes this case....
View Full Document
- Fall '11
- Genetics, Supreme Court of the United States, United States Congress, Biological patent, Myriad Genetics